ArticleFrontiers in pharmacology2022

Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer.

Hang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.